Skip to main content
. Author manuscript; available in PMC: 2024 Aug 2.
Published in final edited form as: Ann Rheum Dis. 2023 Apr 21;82(7):927–936. doi: 10.1136/ard-2022-223808

Table 2.

Frequency of Autoantibodies in Each Cluster Over Time

Cluster 1 (n=137) Cluster 2 (n=376) Cluster 3 (n=80) Cluster 4 (n=212)
Antibody Enrolment Y3 Y5 Enrolment Y3 Y5 Enrolment Y3 Y5 Enrolment Y3 Y5
Sm 78.8 69.3 50.4 5.3 1.3 3.2 11.3 6.3 6.3 21.7 10.4 15.1
U1RNP 95.6 90.5 74.5 8.8 6.6 6.6 12.5 10.0 12.5 25.0 19.3 22.6
DFS70 1.5 1.5 2.2 8.8 9.8 9.6 5.0 5.0 3.8 4.7 4.8 2.8
β2GP1 IgG 4.4 4.4 3.7 4.8 4.3 3.7 46.3 40.0 40.0 7.1 5.2 9.0
β2GP1 IgM 9.5 9.5 2.2 9.6 10.9 3.5 46.3 46.3 31.3 10.4 13.2 3.3
Cardiolipin IgG 13.1 6.6 12.4 8.0 3.7 6.4 55.0 37.5 37.5 20.3 7.1 13.7
Cardiolipin IgM 1.5 1.5 2.2 5.1 2.9 4.8 33.8 22.5 23.8 2.4 4.2 3.3
β2GP1-Domain 1 6.6 4.4 3.7 6.4 4.0 2.7 45.0 50.1 47.5 6.6 4.7 4.7
Lupus anticoagulant 8.61 10.72 8.61 16.03 12.44 8.33 64.85 70.26 60.65 15.07 14.58 10.67
PS/PT IgG 15.3 19.0 10.9 9.8 8.8 5.9 71.3 63.8 61.3 21.7 25.0 20.3
PS/PT IgM 19.0 16.8 13.9 17.6 16.5 8.2 78.8 77.5 62.5 27.8 20.3 16.0
dsDNA 35.0 38.7 33.6 18.9 11.2 9.3 36.3 41.3 40.0 59.0 56.1 56.1
Histone 29.2 21.2 21.2 15.7 6.9 10.9 33.8 21.3 26.3 59.4 46.7 43.4
PCNA 16.8 10.2 13.9 7.4 4.8 12.8 17.5 6.3 18.8 29.2 18.4 31.1
Ribosomal P 33.6 28.5 26.3 11.4 6.1 8.5 23.8 15.0 18.8 41.5 36.3 36.8
Ro52/TRIM21 39.4 29.9 37.2 22.3 18.1 21.3 16.3 17.5 25.0 71.2 69.8 70.8
SSA/Ro60 48.9 42.3 46.0 25.5 22.3 26.3 21.3 21.3 25.0 76.4 79.7 73.6
SSB/La 15.3 7.3 8.0 8.8 6.9 9.0 12.5 8.8 13.8 48.6 39.6 35.4
Centromere B 2.9 0.7 4.4 0.8 1.1 2.1 3.8 3.8 6.3 5.7 6.6 11.8
Jo-1 0.0 0.7 0.7 1.1 1.3 2.4 1.3 0.0 7.5 3.3 0.9 6.6

Darker red shading indicates higher frequency, lighter shading indicates lower frequency of autoantibody

1

n=116 complete data,

2

n=84,

3

n=337,

4

n=237,

5

n=71,

6

n=47,

7

n=180,

8

n=117